Trastuzumab-modified DM1-loaded nanoparticles for HER2 + breast cancer treatment: an in vitro and in vivo study
This record is marked as retracted by the source. Review the publisher’s notice before using its findings.
Source abstract
Abstract
We, the authors, Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Ling Rong, Shuping Zhou, Xinkuang Liu, Amin Li, Tao Jing, Xueke Liu, Yinci Zhang, Shiyu Cai & Xiaolong Tang (2018) Trastuzumab-modified DM1-loaded nanoparticles for HER2+ breast cancer treatment: an in vitro and in vivo study. Artificial Cells, Nanomedicine, and Biotechnology, 46:8, 1708–1718, DOI: 10.1080/21691401.2017.1391821Since publication, the authors noticed errors in Figures 7 b and 5c, which directly impacts the reported results and conclusions. The authors alerted the issue to the Editor and Publisher and all have agreed to retract the article to ensure correction of the scholarly record. The authors plan to re-run the experiment and verify their data.We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: HER2/EGFR in Cancer Research · Monoclonal and Polyclonal Antibodies Research · Peptidase Inhibition and Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Bozhou People’s Hospital Affiliated to Medical College, Anhui University of Science & Technology, Bozhou, China;
Medical College, Anhui University of Science & Technology, Huainan, China;
Huainan First People’s Hospital and First Affiliated Hospital of Medical College, Anhui University of Science & Technology, Huainan, China
Funding
National Natural Science Fund of China · Anhui Provincial Science and Technology program · Huainan Science and Technology Project
References (32)
Show source-provided references
1. 10.7150/thno.857510.7150/thno.8575 ↗
2. 10.1166/jbn.2013.162310.1166/jbn.2013.1623 ↗
3. 10.1007/s10549-014-2925-710.1007/s10549-014-2925-7 ↗
4. 10.5858/arpa.2012-0416-RA10.5858/arpa.2012-0416-RA ↗
5. Wolff AC · Arch Pathol Lab Med · 2007 · 131 · 1810.5858/2007-131-18-ASOCCO ↗
6. 10.1200/JCO.2014.55.787610.1200/JCO.2014.55.7876 ↗
7. 10.1038/bjc.2014.32710.1038/bjc.2014.327 ↗
8. 10.2325/jbcs.13.37410.2325/jbcs.13.374 ↗
9. 10.1208/s12248-012-9386-x10.1208/s12248-012-9386-x ↗
10. 10.1002/cncr.2846510.1002/cncr.28465 ↗
11. 10.1158/1078-0432.CCR-14-209310.1158/1078-0432.CCR-14-2093 ↗
12. 10.1007/s40261-015-0302-x10.1007/s40261-015-0302-x ↗
13. 10.7150/thno.815610.7150/thno.8156 ↗
14. Tang XL · Res Lett · 2014 · 9 · 563
15. 10.1016/j.biomaterials.2007.09.03810.1016/j.biomaterials.2007.09.038 ↗
16. Tang XL · Am J Transl Res · 2014 · 6 · 528
17. 10.1016/j.biomaterials.2014.03.02710.1016/j.biomaterials.2014.03.027 ↗
18. 10.1016/j.msec.2015.10.08710.1016/j.msec.2015.10.087 ↗
19. 10.1039/C4NR03514C10.1039/C4NR03514C ↗
20. 10.1158/1078-0432.CCR-13-107010.1158/1078-0432.CCR-13-1070 ↗
21. 10.3892/or.2013.282510.3892/or.2013.2825 ↗
22. 10.1016/j.bbrc.2013.09.02410.1016/j.bbrc.2013.09.024 ↗
23. 10.1007/s10120-013-0290-610.1007/s10120-013-0290-6 ↗
24. 10.1016/j.canlet.2013.10.01410.1016/j.canlet.2013.10.014 ↗
25. 10.1096/fj.13-23328810.1096/fj.13-233288 ↗
26. 10.1158/0008-5472.CAN-12-180310.1158/0008-5472.CAN-12-1803 ↗
27. 10.1186/bcr348010.1186/bcr3480 ↗
28. 10.1111/his.1214010.1111/his.12140 ↗
29. 10.4161/cbt.2329510.4161/cbt.23295 ↗
30. 10.1158/1078-0432.CCR-12-106310.1158/1078-0432.CCR-12-1063 ↗
31. 10.1166/jbn.2014.184110.1166/jbn.2014.1841 ↗
32. 10.1038/sj.bjc.660569910.1038/sj.bjc.6605699 ↗